Literature DB >> 29224156

Multiplexed and Sensitive DNA Methylation Testing Using Methylation-Sensitive Restriction Enzymes "MSRE-qPCR".

Gabriel Beikircher1, Walter Pulverer1, Manuela Hofner1, Christa Noehammer1, Andreas Weinhaeusel2.   

Abstract

DNA methylation is a chemically stable key-player in epigenetics. In the vertebrate genome the 5-methyl cytosine (5mC) has been found almost exclusively in the CpG dinucleotide context. CpG dinucleotides are enriched in CpG islands very frequently located within or close to gene promoters. Analyses of DNA methylation changes in human diagnostics have been conducted classically using methylation-sensitive restriction enzymes (MSRE). Since the discovery of bisulfite conversion-based sequencing and PCR assays, MSRE-based PCR assays have been less frequently used, although especially in the field of cancer epigenetics MSRE-based genome-wide discovery and targeted screening applications have been and are still performed successfully. Even though epigenome-wide discovery of altered DNA methylation patterns has found its way into various fields of human disease and molecular genetics research, the validation of findings upon discovery is still a bottleneck. Usually several multiples of 10 up to 100 candidate biomarkers from discovery have to be confirmed or are of interest for further work. In particular, bisulfite PCR assays are often limited in the number of candidates which can be analyzed, due to their low multiplexing capability, especially, if only small amounts of DNA are available from for example clinical specimens. In clinical research and diagnostics a similar situation arises for the analyses of cell-free DNA (cfDNA) in body fluids or circulating tumor cells (CTCs). Although tissue- or disease- (e.g., cancer) specific DNA methylation patterns can be deduced very efficiently in a genome-wide manner if around 100 ng of DNA are available, confirming these candidates and selecting target-sequences for studying methylation changes in liquid biopsies using cfDNA or CTCs remains a big challenge. Along these lines we have developed MSRE-qPCR and introduce here method details, which have been found very suitable for the efficient confirmation and testing of DNA methylation in a quantitative multiplexed manner (e.g., 48-96 plex) from ng amounts of DNA. The method is applicable in a standard qPCR setting as well for nanoliter scaled high-throughput qPCR, enabling detection of <10 copies of targets, thus suitable to pick up 0.1-1% of specific methylated DNA in an unmethylated background.

Entities:  

Keywords:  DNA methylation; MSRE-qPCR; Methylation-sensitive restriction enzyme; Multiplex; qPCR

Mesh:

Substances:

Year:  2018        PMID: 29224156     DOI: 10.1007/978-1-4939-7481-8_21

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

1.  Oxytocin receptor gene methylation as a molecular marker for severity of depressive symptoms in affective disorder patients.

Authors:  Birgit Ludwig; Laura Carlberg; Klemens Kienesberger; Patrick Swoboda; Marleen M M Swoboda; Alexandra Bernegger; Romina Koller; Michelle Inaner; Monika Fuxjäger; Melanie Zotter; Nicolas Schmelzle; Birgit Senft; Lisa Meisner; Daniela Fischer-Hansal; Jasmin Huber; Silvia Schoenthaler; Nestor D Kapusta; Helmuth Haslacher; Martin Aigner; Andreas Weinhaeusel; Siegfried Kasper; Alexandra Schosser
Journal:  BMC Psychiatry       Date:  2022-06-07       Impact factor: 4.144

2.  Age-Related Macular Degeneration: From Epigenetics to Therapeutic Implications.

Authors:  Michael H Farkas; Margaret M DeAngelis
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 3.650

3.  Identification of tumor tissue-derived DNA methylation biomarkers for the detection and therapy response evaluation of metastatic castration resistant prostate cancer in liquid biopsies.

Authors:  Thomas Dillinger; Raheleh Sheibani-Tezerji; Walter Pulverer; Ines Stelzer; Melanie R Hassler; Janine Scheibelreiter; Carlos Uziel Pérez Malla; Madeleine Kuroll; Sandra Domazet; Elisa Redl; Sarah Ely; Stefanie Brezina; Andreas Tiefenbacher; Katharina Rebhan; Nicolai Hübner; Bernhard Grubmüller; Markus Mitterhauser; Marcus Hacker; Andreas Weinhaeusel; Judit Simon; Markus Zeitlinger; Andrea Gsur; Gero Kramer; Shahrokh F Shariat; Lukas Kenner; Gerda Egger
Journal:  Mol Cancer       Date:  2022-01-03       Impact factor: 27.401

Review 4.  Next-generation sequencing in liquid biopsy: cancer screening and early detection.

Authors:  Ming Chen; Hongyu Zhao
Journal:  Hum Genomics       Date:  2019-08-01       Impact factor: 4.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.